日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical, pathological and prognostic features of surgically excised cutaneous and subcutaneous digital and distal limb mast cell tumours in dogs

犬皮肤及皮下指部和远端肢体肥大细胞瘤手术切除的临床、病理及预后特征

Erickson, A K; Tremolada, G; Sztukowski, K E; Thamm, D H; Husbands, B D

c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

c-Kit突变和定位状态作为犬肥大细胞瘤患者接受泼尼松和托西拉尼或长春碱治疗的疗效预测因子

Weishaar, K M; Ehrhart, E J; Avery, A C; Charles, J B; Elmslie, R E; Vail, D M; London, C A; Clifford, C A; Eickhoff, J C; Thamm, D H

Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma

雷巴福沙定/阿霉素交替用药:在初治犬多中心淋巴瘤中的疗效和耐受性

Thamm, D H; Vail, D M; Post, G S; Fan, T M; Phillips, B S; Axiak-Bechtel, S; Elmslie, R S; Klein, M K; Ruslander, D A

Canine Cutaneous Plasmacytosis: 21 Cases (2005-2015)

犬皮肤浆细胞增多症:21 例(2005-2015 年)

Boostrom, B O; Moore, A S; DeRegis, C J; Robat, C; Freeman, K; Thamm, D H

The Flint Animal Cancer Center (FACC) Canine Tumour Cell Line Panel: a resource for veterinary drug discovery, comparative oncology and translational medicine

弗林特动物癌症中心(FACC)犬类肿瘤细胞系库:兽药研发、比较肿瘤学和转化医学的资源

Fowles, J S; Dailey, D D; Gustafson, D L; Thamm, D H; Duval, D L

Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.

脉冲式给药磷酸托西拉尼联合洛莫司汀治疗犬类不可切除的肥大细胞瘤

Burton J H, Venable R O, Vail D M, Williams L E, Clifford C A, Axiak-Bechtel S M, Avery A C, Thamm D H

Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma

比较470只因肢体骨肉瘤截肢后采用卡铂和多柔比星化疗方案的疗效

Selmic, L E; Burton, J H; Thamm, D H; Withrow, S J; Lana, S E

Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphoma

VDC-1101治疗犬皮肤T细胞淋巴瘤的II期临床试验

Morges, M A; Burton, J H; Saba, C F; Vail, D M; Burgess, K E; Thamm, D H

Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.

针对可测量的犬肥大细胞瘤,开展低分割放射治疗、托西拉尼和泼尼松的多中心前瞻性试验

Carlsten K S, London C A, Haney S, Burnett R, Avery A C, Thamm D H

NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging

NOD/SCID小鼠犬T细胞淋巴瘤模型伴体液性高钙血症:细胞因子基因表达谱分析和体内生物发光成像

Nadella, M V P; Kisseberth, W C; Nadella, K S; Thudi, N K; Thamm, D H; McNiel, E A; Yilmaz, A; Boris-Lawrie, K; Rosol, T J